{"database":"MetabolomicsWorkbench","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["http://www.metabolomicsworkbench.org/rest/study/study_id/ST001242/mwtab"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"technology_type":["Mass Spectrometry","ESI"],"disease":["Down Syndrome"],"full_dataset_link":["http://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST001242"],"study_factor":["Cohort:T21","Cohort:D21"],"tissue":["Cerebrospinal Fluid"],"sample_protocol":["Reversed phase POSITIVE ION MODE. Reversed phase NEGATIVE ION MODE."],"repository":["MetabolomicsWorkbench"],"data_protocol":[""],"omics_type":["Metabolomics"],"species":["Homo Sapiens"],"submitter_affiliation":["University of Colorado Denver"],"metabolite_name":["N-Acetylneuraminate","Taurine","Prostaglandin G2","hexanoyl-L-carnitine","Arachidonic acid","Docosahexaenoic acid","L-arginine","Octanoic acid","Spermidine","5-Guanidino-2-oxopentanoate","Heptanoic acid","D-Glyceraldehyde 3-phosphate","L-asparagine","L-Citrulline","L-glutamine","Succinate","8-Methoxykynurenate","a-Linolenic acid","Hydroxybutyrylcarnitine","L-alanine","L-phenylalanine","Undecanoic acid","L-lysine","L-methionine","Octadecenoic acid","Hexanoic acid","N-Acetylornithine","Picolinic acid","Urate","Mannitol","5-6-Dihydrothymine","trans-4-Hydroxy-L-proline","L-cystine","Creatinine","L-threonine","Serotonin","(5-L-Glutamyl)-L-glutamine","N6-Methyl-L-lysine","Xanthine","Tetradecenoic acid","L-serine","L-Formylkynurenine","Fumarate","Choline","Acetylcholine","Vanillate","Glycerol 3-phosphate","2-Oxoglutarate","Lactate","D-Glucose-phosphate","4-Acetamidobutanoate","Citrate","L-histidine","L-Kynurenine","Ascorbate","L-tryptophan","Creatine","Octadecanoic acid","N-Acyl-D-mannosaminolactone","2',3'-Cyclic CMP","Dehydroascorbate","5-Oxoproline","Pyridoxamine 5'-phosphate","g-Oxalo-crotonate","gamma-Glutamyl-Se-methylselenocysteine","Prostaglandin D2","L-Methionine S-oxide","Tetradecanoic acid","2-Oxo-7-methylthioheptanoic acid","Malate","Hypoxanthine","L-Homocysteine","D-Arabitol","Ornithine","Decanoic acid","D-Glucose","5-Hydroxyisourate","L-leucine","2-Deoxy-alpha-D-glucoside","propionyl-carnitine","Dodecanoic acid","acetyl-carnitine","gamma-L-Glutamyl-D-alanine","10-Hydroxydecanoic acid","Phospho-D-glycerate","D-Rhamnose","Homocarnosine","L-proline","L-Carnitine","Quinolinic acid","Adenosine","Catechin","6-Pyruvoyltetrahydropterin","Hexadecenoic acid","Pyruvate","L-glutamate","13(S)-HODE","Linoleic acid","Anthranilate","D-Ribose","butanoyl-l-carnitine","L-valine","L-tyrosine","Inosine","Dimethylglycine"],"name_synonyms":["XX, leukemia, XY, Trisomy 21 NOS, 47, determination, G Trisomy, EBR2A, Down Syndrome, Trisomy 21, Down's Syndrome, GM-CSF, Complete trisomy 21 syndrome, spinal fluid, B2T, Down's syndrome NOS (disorder), cerebral spinal fluid, Complete trisomy 21 syndrome (disorder), +21, Sargramostim, chemical analysis, liquor cerebrospinalis, Down's, EBR2., trisomy 21 syndrome, GMCSF, Down's syndrome - trisomy 21, LAMB2T, Trisomy 21 Syndrome, Partial Trisomy 21 Down Syndrome, Down's syndrome NOS, Down syndrome chromosome region, BM600, Trisomy G, of Down syndrome, complete trisomy 21 syndrome, CSF, Mitotic Nondisjunction, Colony-stimulating factor, Csfgm, Mongolism, Down, Molgramostin, trisomy 21, Meiotic Nondisjunction, Down syndrome, Syndrome, Down syndrome critical region, LAMNB2, Cerebral Spinal Fluid, megakaryoblastic, transient myeloproliferative disorder of Down syndrome, T21 - Trisomy 21, assay, Partial Trisomy 21, Downs Syndrome"],"sample_synonyms":["backward, reversed., reversed"],"additional_accession":[]},"is_claimable":false,"name":"Global Metabolic Analysis Trisomy 21 - Cohort 3, CSF","description":null,"dates":{"publication":""},"accession":"ST001242","cross_references":{"TAXONOMY":["9606"]}}